NeuroLambda Therapeutics

About NeuroLambda Therapeutics

We are a seed-stage biotech startup, head-quartered in Cambridge, MA. We are currently raising our next round of $10M to take our lead program through IND-enabling studies, as well as expand our pipeline in a resource efficient way with the help of large-scale computational modeling. Our vision is to transform the therapeutic landscape of neurological disorders, through brain-penetrant oral medicines discovered with a paradigm-shifting approach powered by large-scale computation. The team comprises leading scientists who have pioneered physics-based computational modeling with an unparalleled track record in delivering high value clinical candidates, working together with top industry veterans with decades of experience in drug R&D, as well as world class academic collaborators. As a member of the Nvidia Inception program, we leverage cloud gpus on AWS and Google Cloud Platform (GCP) at scale for our in-house designs and computational modeling, together with a network of CRO partners for synthesis, assays, and structural biology. We can flexibly scale both compute and wet lab resources up or down as needed. More details will follow in the future, when we are out of stealth mode!

View contact profiles from NeuroLambda Therapeutics